Reduction of NOS2 overexpression in rheumatoid arthritis patients treated with anti-tumor necrosis factor alpha monoclonal antibody (cA2) (Q77742355)
Jump to navigation
Jump to search
scientific article published on 01 December 1998
Language | Label | Description | Also known as |
---|---|---|---|
English | Reduction of NOS2 overexpression in rheumatoid arthritis patients treated with anti-tumor necrosis factor alpha monoclonal antibody (cA2) |
scientific article published on 01 December 1998 |
Statements
Reduction of NOS2 overexpression in rheumatoid arthritis patients treated with anti-tumor necrosis factor alpha monoclonal antibody (cA2) (English)
St Clair EW
Perkins DJ
Misukonis MA
1 December 1998